Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Rosenau

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Transplantation|August 21, 2013
Hepatitis C virus infection in heart transplantation: is ventricular assist device therapy an option?Navin Rajagopalan, Charles W Hoopes, Jens Rosenau
Gastroenterology|November 28, 2002
Discussion on the association between hepatitis C infection and survival after orthotopic liver transplantationMatthias J Bahr, Jens Rosenau, Michael P Manns
Clinical Transplantation|January 28, 2012
High rate of unperceived hearing loss in patients after liver transplantationKinan Rifai, Sven Pischke, Clemens Agne, et al.
Scandinavian Journal of Gastroenterology|September 23, 2006
Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus)Kinan Rifai, Carsten Hafer, Jens Rosenau, et al.
Artificial Organs|October 13, 2009
Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorptionKinan Rifai, Anibh Das, Jens Rosenau, et al.
Clinical Transplantation|April 12, 2007
Longer survival of liver transplant recipients with hepatitis virus coinfectionsKinan Rifai, Heiner Wedemeyer, Jens Rosenau, et al.
Antiviral Therapy|August 5, 2008
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levelsJohannes Wiegand, Heiner Wedemeyer, Andrea Finger, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2008
Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantationNazanin Hooman, Kinan Rifai, Johannes Hadem, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 4, 2006
A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantationKinan Rifai, Gabriele I Kirchner, Matthias J Bahr, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 24, 2007
Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantationJens Rosenau, Nazanin Hooman, Johannes Hadem, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Transplantation|August 21, 2013
Hepatitis C virus infection in heart transplantation: is ventricular assist device therapy an option?Navin Rajagopalan, Charles W Hoopes, Jens Rosenau
Gastroenterology|November 28, 2002
Discussion on the association between hepatitis C infection and survival after orthotopic liver transplantationMatthias J Bahr, Jens Rosenau, Michael P Manns
Clinical Transplantation|January 28, 2012
High rate of unperceived hearing loss in patients after liver transplantationKinan Rifai, Sven Pischke, Clemens Agne, et al.
Scandinavian Journal of Gastroenterology|September 23, 2006
Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus)Kinan Rifai, Carsten Hafer, Jens Rosenau, et al.
Artificial Organs|October 13, 2009
Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorptionKinan Rifai, Anibh Das, Jens Rosenau, et al.
Clinical Transplantation|April 12, 2007
Longer survival of liver transplant recipients with hepatitis virus coinfectionsKinan Rifai, Heiner Wedemeyer, Jens Rosenau, et al.
Antiviral Therapy|August 5, 2008
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levelsJohannes Wiegand, Heiner Wedemeyer, Andrea Finger, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2008
Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantationNazanin Hooman, Kinan Rifai, Johannes Hadem, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 4, 2006
A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantationKinan Rifai, Gabriele I Kirchner, Matthias J Bahr, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 24, 2007
Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantationJens Rosenau, Nazanin Hooman, Johannes Hadem, et al.
Pageof 2